Kings College Hospital - Haematology

London SE5 9RS

2 studies enrolling now · 6 studies all time

What they study most

Carcinoma, Hepatocellular, Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Sickle Cell Disease, Thalassemia

Studies at this site

• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease — Recruiting now
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia — Recruiting now
• A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS) — Running, not enrolling
• A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) — Completed
• A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma — Completed
• FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients — Completed